Nkarta, Inc.

US$1.73As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NKTXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (34.98%)
Div yield —
ROE (46.58%)
Biotechnology
Beta (5Y) 1.25
PE TTM —
TSR TTM (18.01%)
Mkt cap US$124.0M
ROIC (23.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.82
5.00%
(33.61%)
Hold 12|4|11|1|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
19.77%
18.65%
28.88%
27.20%
Revenue$M
7.580
7.570
7.720
7.654
14.65%
8.51%
8.36%
4.51%
Peers (US$124.0M)
Cap (US$)
PE
124.5M
—
118.3M
—
Capital
TTM
5Y
10Y
Leveragex
1.704
0.161
0.133
EBIT/Intx
1.004
0.144
0.173
Own earn%
(11.39)
(40.58)
(52.56)
Sh yield%
29.02
22.57
20.87
Owners
Insiders/Inst%
0.78
38.02
Short interest%
4.01
SBC / revenue%
0.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
26–33
$1 testx
0.0
Incr. ROIC%
4